JY
BHVN

Jeff Yass’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Jeff Yass’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-149,100
Closed -$22.5M – 14736
2022
Q3 		$22.5M Buy
149,100
+63,100
+73% +$9.35M 0.01% 1332
2022
Q2 		$12.5M Sell
86,000
-128,400
-60% -$16.4M ﹤0.01% 1923
2022
Q1 		$25.4M Sell
214,400
-8,200
-4% -$1.02M ﹤0.01% 1487
2021
Q4 		$30.7M Buy
222,600
+31,400
+16% +$3.99M ﹤0.01% 1448
2021
Q3 		$26.6M Sell
191,200
-340,500
-64% -$42.5M ﹤0.01% 1698
2021
Q2 		$51.6M Buy
531,700
+176,200
+50% +$14.3M 0.01% 1186
2021
Q1 		$24.3M Sell
355,500
-249,700
-41% -$20.2M ﹤0.01% 1667
2020
Q4 		$51.9M Buy
605,200
+452,500
+296% +$38.3M 0.01% 982
2020
Q3 		$9.93M Sell
152,700
-67,800
-31% -$4.44M ﹤0.01% 2188
2020
Q2 		$16.1M Sell
220,500
-123,800
-36% -$6.59M ﹤0.01% 1643
2020
Q1 		$11.7M Buy
344,300
+35,600
+12% +$1.63M ﹤0.01% 1583
2019
Q4 		$16.8M Buy
308,700
+87,200
+39% +$4.32M ﹤0.01% 1585
2019
Q3 		$9.24M Buy
221,500
+143,300
+183% +$6.05M ﹤0.01% 2060
2019
Q2 		$3.42M Sell
78,200
-5,800
-7% -$327K ﹤0.01% 3251
2019
Q1 		$4.32M Sell
84,000
-29,000
-26% -$1.25M ﹤0.01% 2631
2018
Q4 		$4.18M Buy
113,000
+85,400
+309% +$3.08M ﹤0.01% 2500
2018
Q3 		$1.04M Sell
27,600
-7,300
-21% -$269K ﹤0.01% 5152
2018
Q2 		$1.38M Buy
34,900
+21,300
+157% +$676K ﹤0.01% 4707
2018
Q1 		$350K Sell
13,600
-1,000
-7% -$29.9K ﹤0.01% 7366
2017
Q4 		$394K Buy
+14,600
New +$402K ﹤0.01% 7092

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $6.8B AUM 23.31% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Jeff Yass's BHVN Position: Q4 2022 in Review

Jeff Yass sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 36,591 shares — an estimated $5.53M sold.

Jeff Yass first reported a position in BHVN in Q3 2017 and held it in 20 quarters. The position peaked at $27.2M in Q4 2020. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Jeff Yass reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Jeff Yass sold 36,591 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $5.53M.
  • Jeff Yass first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2017 and held it in 20 quarters.
  • Jeff Yass's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $27.2M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.